Healthcare / Health Information ServicesTSXV
$0.23
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 12%
FCF escenarios
weak_data · normalized FCF $-2.2M · quality 28.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
12/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$27M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-1838.8%
↓Gross Margin
-909.0%
↓Debt/Equity
13.18
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-38.2%
FCF CAGR
—
FCF margin
-3517.6%
FCF / Net income
0.85x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $103797.0 · net income $-4.3M · FCF $-3.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $103797.00 | $103797.00 | $170158.00 | $485749.00 | $438833.00 |
| Net Income | $-4.3M | $-4.3M | $-3.1M | $-2.5M | $-2.6M |
| EBITDA | $-3.6M | $-3.6M | $-2.4M | $-2.1M | $-2.4M |
| EPS | -0.05 | -0.05 | -0.04 | -0.04 | -0.04 |
| Gross Margin | -909.0% | -909.0% | -492.4% | -63.2% | -95.3% |
| Operating Margin | -3671.7% | -3671.7% | -1522.5% | -457.4% | -605.4% |
| Net Margin | -4129.6% | -4129.6% | -1833.9% | -510.7% | -594.4% |
| Balance Sheet | |||||
| Debt/Equity | 13.18 | 13.18 | -1.04 | -1.18 | -10.45 |
| Current Ratio | 1.75 | 1.75 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-3.7M | $-3.7M | $-2.2M | $-1.9M | $-2.1M |
| Returns | |||||
| ROE | -1838.8% | -1838.8% | 102.3% | 127.3% | 2297.8% |
| Valuation | |||||
| P/B | 87.10 | 87.10 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | -39.0% | -39.0% | -65.0% | 10.7% | — |
| EPS Growth | -25.0% | -25.0% | 0.0% | 0.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.04 → -0.05
Residual
+0.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.